GVA effects triggered by global biopharmaceutical industry activities 2020
According to estimates from 2020, some 532 billion U.S. dollars were contributed to the global GDP due to worldwide biopharmaceutical industry economic activity. This statistic illustrates the gross value added effects triggered by global biopharmaceutical industry economic activities worldwide, by level of effect.